These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7820067)
21. Release of acetylcholinesterase from the guinea-pig substantia nigra during peripheral nerve stimulation. Taylor SJ; Greenfield SA Brain Res; 1989 Mar; 482(2):356-8. PubMed ID: 2706493 [TBL] [Abstract][Full Text] [Related]
22. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra. Biggs CS; Fisher A; Starr MS Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134 [TBL] [Abstract][Full Text] [Related]
23. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum. Biggs CS; Starr MS Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum. Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423 [TBL] [Abstract][Full Text] [Related]
25. Rat locomotion and release of acetylcholinesterase. Heiland B; Greenfield SA Pharmacol Biochem Behav; 1999 Jan; 62(1):81-7. PubMed ID: 9972849 [TBL] [Abstract][Full Text] [Related]
26. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin. Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027 [TBL] [Abstract][Full Text] [Related]
27. Neurotensin-dopamine interactions in the substantia nigra of the rat brain. Merchant KM; Bush LG; Gibb JW; Hanson GR J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039 [TBL] [Abstract][Full Text] [Related]
28. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra. Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297 [TBL] [Abstract][Full Text] [Related]
29. A peptide derived from the C-terminal region of acetylcholinesterase modulates extracellular concentrations of acetylcholinesterase in the rat substantia nigra. Emmett SR; Greenfield SA Neurosci Lett; 2004 Apr; 358(3):210-4. PubMed ID: 15039118 [TBL] [Abstract][Full Text] [Related]
30. Uptake of acetylcholinesterase by neurons in the substantia nigra. Dickie BG; Budd TC; Vaux D; Greenfield SA Eur J Neurosci; 1995 Mar; 7(3):351-7. PubMed ID: 7773434 [TBL] [Abstract][Full Text] [Related]
31. On-line visualization of dendritic release of acetylcholinesterase from mammalian substantia nigra neurons. Llinás RR; Greenfield SA Proc Natl Acad Sci U S A; 1987 May; 84(9):3047-50. PubMed ID: 3472250 [TBL] [Abstract][Full Text] [Related]
32. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine. Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545 [TBL] [Abstract][Full Text] [Related]
33. Biotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists. Sarre S; Vandeneede D; Ebinger G; Michotte Y J Neurochem; 1998 Apr; 70(4):1730-9. PubMed ID: 9523592 [TBL] [Abstract][Full Text] [Related]
34. Release of acetylcholinesterase in the rat nigrostriatal pathway: relation to receptor activation and firing rate. Weston J; Greenfield SA Neuroscience; 1986 Apr; 17(4):1079-88. PubMed ID: 3714040 [TBL] [Abstract][Full Text] [Related]
35. Carotid body dopamine content and release by short-term hypoxia: effect of haloperidol and alpha methyl paratyrosine. Basson H; Bairam A; Cottet-Emard JM; Pequignot JM; Marchal F Arch Physiol Biochem; 1997 Feb; 105(1):3-9. PubMed ID: 9224540 [TBL] [Abstract][Full Text] [Related]
36. Characterization of dopaminergic influence on striatal-nigral neurotensin systems. Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151 [TBL] [Abstract][Full Text] [Related]
37. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain. Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544 [TBL] [Abstract][Full Text] [Related]
38. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats. Gołembiowska K; Dziubina A Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831 [TBL] [Abstract][Full Text] [Related]
39. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent. Cobb WS; Abercrombie ED Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698 [TBL] [Abstract][Full Text] [Related]
40. Release of acetylcholinesterase and aminopeptidase in vivo following infusion of amphetamine into the substantia nigra. Greenfield SA; Shaw SG Neuroscience; 1982; 7(11):2883-93. PubMed ID: 7155357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]